Current Clinical Use of Reteplase for Thrombolysis
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 36 (4) , 265-276
- https://doi.org/10.2165/00003088-199936040-00002
Abstract
Clinical evaluation of a new thrombolytic agent should start with a dose that provides adequate efficacy and has an acceptably low bleeding risk; this results in a narrow therapeutic window at the...Keywords
This publication has 46 references indexed in Scilit:
- Dose finding with a novel recombinant plasminogen activator (BM 06,022) in patients with acute myocardial infarction: Results of the German recombinant plasminogen activator studyJournal of the American College of Cardiology, 1994
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Open, noncontrolled dose-finding study with a novel recombinant plasminogen activator (BM 06.022) given as a double bolus in patients with acute myocardial infarctionThe American Journal of Cardiology, 1993
- Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: Retrospective analysis of four german multicenter studiesJournal of the American College of Cardiology, 1993
- Differential fibrinolytic properties of the recombinant plasminogen activator BM 06.022 in human plasma and blood clot systems in vitroBlood Coagulation & Fibrinolysis, 1993
- Rapid Reversal of Canine Thromboembolic Pulmonary Hypertension by Bolus Injection of the Novel Recombinant Plasminogen Activator BM 06.022Journal of Cardiovascular Pharmacology, 1993
- Bolus Application of a Novel Recombinant Plasminogen Activator in Acute Myocardial Infarction Patients: Pharmacokinetics and Effects on the Hemostatic SystemAnnals of the New York Academy of Sciences, 1992
- Evaluation of thrombolytic and systemic effects of the novel recombinant plasminogen activator BM 06.022 compared with alteplase, anistreplase, streptokinase and urokinase in a canine model of coronary artery thrombosisJournal of the American College of Cardiology, 1992
- Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1989
- Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosisThe American Journal of Cardiology, 1986